N C Levitt
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
- Molecular Biology top 10%
- DNA Repair Mechanisms 4
- Cancer therapeutics and mechanisms 2
- Metabolomics and Mass Spectrometry Studies 1
- Oncology top 10%
- Lung Cancer Research Studies 2
-
- Microtubule and mitosis dynamics 2
-
- Glioma Diagnosis and Treatment 2
-
- Medical Imaging Techniques and Applications 1
- Co-authors
- Ian D. HicksonNicholas ProudfootDaniel BriggsA GilSally L. DaviesLeonard WuAdrian L. HarrisDavid Propper
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
N C Levitt
14 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Cancer Research 291
- Molecular Biology 847
- Oncology 236
- Cell Biology 81
- Virology 22
Countries citing papers authored by N C Levitt
This map shows the geographic impact of N C Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N C Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N C Levitt more than expected).
Fields of papers citing papers by N C Levitt
This network shows the impact of papers produced by N C Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N C Levitt. The network helps show where N C Levitt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N C Levitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2011 | 37 | |
| 3 | 2008 | 45 | |
| 4 | 2005 | 5 | |
| 5 | Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression. | 2003 | 22 |
| 6 | 2002 | 77 | |
| 7 | Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. | 2001 | 106 |
| 8 | 2001 | 243 | |
| 9 | 2001 | 36 | |
| 10 | 2000 | 14 | |
| 11 | 2000 | 2 | |
| 12 | 1999 | 103 | |
| 13 | 1991 | 100 | |
| 14 | 1989 | 254 |
About N C Levitt
N C Levitt is a scholar working on Genetics, Oncology and Cancer Research, having authored 14 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Glioma Diagnosis and Treatment (2 papers), Microtubule and mitosis dynamics (2 papers), Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Cancer Research (291 citations), Molecular Biology (847 citations) and Oncology (236 citations). N C Levitt has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Ian D. Hickson, Nicholas Proudfoot, Daniel Briggs, A Gil, Sally L. Davies, Leonard Wu, Adrian L. Harris, David Propper, Jeremy Braybrooke and Trivadi S. Ganesan. Their work appears in journals such as British Journal of Cancer, JNCI Monographs, The EMBO Journal, Trends in Molecular Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.